| |
| |
|
| Insider
Information: |
Leonard Braden Michael |
| Relationship: |
|
| City: |
Zionsville |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
11 |
|
| Direct
Shares |
2,570,043 |
|
|
Indirect Shares
|
42,957,502 |
|
|
| Direct
Value |
$12,599,089 |
|
|
|
Indirect Value
|
$204,192,642 |
|
|
| Total
Shares |
45,527,545 |
|
|
| Total
Value |
$216,791,731 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
30
|
4
|
|
Stock
price went up :
|
4
|
1
|
| Stock
price went down : |
26
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 123.8%
|
2,039.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Build A Bear Workshop Inc |
BBW |
Former Director of the... |
2017-09-29 |
142,043 |
2017-09-29 |
1,281,000 |
Premium* |
|
|
Prophase Labs Inc |
PRPH |
10% Owner |
|
0 |
2017-09-29 |
627,322 |
Premium* |
|
|
Orchids Paper Products Co /de |
TIS |
10% Owner |
2019-04-03 |
128,000 |
2019-04-03 |
1,329,963 |
Premium* |
|
|
Disc Medicine, Inc |
IRON |
10% Owner |
2022-10-26 |
247,500 |
2022-10-26 |
5,000,000 |
Premium* |
|
|
Enliven Therapeutics Ord Shs |
ELVN |
10% Owner |
2023-01-04 |
230,000 |
2023-01-04 |
1,767,774 |
Premium* |
|
|
Retractable Technologies Inc |
RVP |
10% Owner |
2022-12-29 |
387,500 |
2022-12-29 |
688,575 |
Premium* |
|
|
Astrotech Corporation |
ASTC |
10% Owner |
2022-12-02 |
350,000 |
2022-12-02 |
6,612,311 |
Premium* |
|
|
Metacrine, Inc. |
MTCR |
10% Owner |
2022-12-21 |
600,000 |
2022-12-21 |
6,160,570 |
Premium* |
|
|
Satsuma Pharmaceuticals, Inc. |
STSA |
10% Owner |
2022-11-21 |
150,000 |
2022-11-21 |
6,440,000 |
Premium* |
|
|
Aclaris Therapeutics, Inc. |
ACRS |
|
|
0 |
2024-02-07 |
9,395,934 |
Premium* |
|
|
Cyteir Therapeutics, Inc. |
CYT |
|
2024-03-20 |
335,000 |
2024-03-20 |
3,654,053 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CYT |
Cyteir Therapeutics, Inc. |
|
• • • |
2024-03-20 |
4 |
B |
$2.95 |
$503,238 |
I/I |
170,589 |
3,654,053 |
0.01 |
- |
|
| CYT |
Cyteir Therapeutics, Inc. |
|
• • • |
2024-03-18 |
4 |
B |
$3.01 |
$342,469 |
I/I |
113,777 |
3,483,464 |
0.01 |
- |
|
| CYT |
Cyteir Therapeutics, Inc. |
|
– – • |
2024-03-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
335,000 |
|
- |
|
| CYT |
Cyteir Therapeutics, Inc. |
|
– – • |
2024-03-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,369,687 |
|
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
|
– – • |
2024-02-07 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
9,395,934 |
|
% |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2023-01-04 |
4 |
S |
$4.00 |
$5,000,000 |
I/I |
(1,250,000) |
1,767,774 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2023-01-03 |
4/A |
S |
$4.00 |
$5,000,000 |
I/I |
(1,250,000) |
1,767,774 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2022-12-30 |
4 |
S |
$4.04 |
$80,800 |
D/D |
(20,000) |
230,000 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2022-12-29 |
4 |
S |
$4.04 |
$80,166 |
D/D |
(19,843) |
250,000 |
0 |
- |
|
| RVP |
Retractable Technologies ... |
10% Owner |
– – • |
2022-12-29 |
4 |
S |
$1.60 |
$4,800,000 |
I/I |
(3,000,000) |
688,575 |
0 |
% |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2022-12-28 |
4 |
S |
$4.04 |
$634 |
D/D |
(157) |
269,843 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2022-12-23 |
4 |
S |
$4.06 |
$198,623 |
D/D |
(48,922) |
270,000 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2022-12-22 |
4 |
S |
$4.06 |
$4,377 |
D/D |
(1,078) |
318,922 |
0 |
- |
|
| MTCR |
Metacrine, Inc. |
10% Owner |
– – • |
2022-12-21 |
4 |
B |
$0.40 |
$48,040 |
I/I |
120,099 |
6,160,570 |
1.5 |
- |
|
| MTCR |
Metacrine, Inc. |
10% Owner |
– – • |
2022-12-20 |
4 |
B |
$0.38 |
$19,001 |
I/I |
50,122 |
6,040,471 |
1.5 |
- |
|
| MTCR |
Metacrine, Inc. |
10% Owner |
– – • |
2022-12-19 |
4 |
B |
$0.40 |
$40,554 |
I/I |
101,384 |
5,990,349 |
1.5 |
- |
|
| ASTC |
Astrotech Corporation |
10% Owner |
– – • |
2022-12-02 |
4 |
B |
$0.34 |
$65,599 |
I/I |
190,971 |
6,612,311 |
1.5 |
- |
|
| RVP |
Retractable Technologies ... |
10% Owner |
– – • |
2022-11-29 |
4 |
S |
$2.00 |
$500,000 |
I/I |
(250,000) |
3,688,575 |
0 |
% |
|
| RVP |
Retractable Technologies ... |
10% Owner |
– – • |
2022-11-28 |
4 |
S |
$2.30 |
$5,524 |
I/I |
(2,400) |
3,918,575 |
0 |
% |
|
| STSA |
Satsuma Pharmaceuticals, ... |
10% Owner |
– – • |
2022-11-21 |
4 |
B |
$0.71 |
$106,740 |
D/D |
150,000 |
150,000 |
2.45 |
- |
|
| ASTC |
Astrotech Corporation |
10% Owner |
– – • |
2022-11-18 |
4 |
B |
$0.39 |
$51,751 |
I/I |
133,688 |
6,346,340 |
1.5 |
% |
|
| ASTC |
Astrotech Corporation |
10% Owner |
– – • |
2022-11-17 |
4 |
B |
$0.36 |
$33,900 |
I/I |
93,879 |
6,212,652 |
1.5 |
% |
|
| ASTC |
Astrotech Corporation |
10% Owner |
– – • |
2022-11-16 |
4 |
B |
$0.36 |
$59,289 |
I/I |
162,928 |
6,118,733 |
1.5 |
% |
|
| STSA |
Satsuma Pharmaceuticals, ... |
10% Owner |
– – • |
2022-11-15 |
4 |
B |
$0.63 |
$525,663 |
I/I |
831,694 |
6,440,000 |
1.5 |
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
10% Owner |
– – • |
2022-11-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,608,306 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
